Product 8/9
Methyl Masterdrol gives you the most intense experience in the gym of any prohormone. It imparts amazing energy, strength and focus giving you the best workouts of your life. The unique ingredient in Methyl Masterdrol will give you the intensity to push past even your toughest plateau and recruit more strength than you've ever seen before! Methyl Masterdrol is perfect to use alone, for anyone that wishes to increase strength and stamina or as part of our stack that included Methyl 1-D for amazing mass and outstanding focus. The new rapid release sublingual tablets are designed to instantly release more active ingredients into your system and bypass the liver and stomach, making the bioavailability skyrocket. Also included are support ingredients that further increase the leaning out process and boosting the anabolic environment. Masterdrol is not a mass product on it's own, it does a good job of increasing strength, intensity and focus in the gym, without bloat or water retention. Alone, it is a perfect “cutter” product and stacked with Methyl 1-D, it provides the perfect addition to boost vascularity and strength. Methyl Masterdrol can be used in cycles of up to 8 weeks for very hard core users. As with all hormone products, temporary reduction in natural testosterone production can occur and should recover naturally after a cycle. If you wish, you can use Formadrol for Post Cycle Therapy to decrease the time of your natural recovery. Supplement Facts: Serving Size: 1 Sublingual Tablet Servings per Container: 135 Per Serving: Prohormone: 3-beta-hydroxyetioallocholan-17-one: 100mg Metabolism Complex (Patent Pending): 150mg Caprylic Acid (from Sodium caprylate) Piperine Zinc Aspartate Coleus Forskolin Standardized Yohimbe (Standardized for 99% Yohimbine) Other Ingredients: Amidosarcosine Ester, Croscarmellose Sodium, Sodium Starch Glyconate, DiCalcium Phosphate Dihydrate, Magnesium Stearate, Gelatin, FD&C Red Dye #40, FD&C Blue Dye #1, Titanium Dioxide.
This product was added to our catalog on Monday 19 October, 2009.